EUVIMEDEUVIMED entdecken
LeserbriefOpen Access

Topical ruxolitinib ± oral baricitinib in the treatment of active non‐segmental vitiligo: A retrospective analysis

Yaohua Zhang iD, Tingting Zhu iD, Xianfa Tang, Weiran Li, He Huang, Yujun Sheng, Min Li, Yong Cui iD, Xuejun Zhang iD, Leihong Xiang iD, Bo Zhang iD

Journal of the European Academy of Dermatology and Venereology · 2026-08 · 40 (8)

DOI: 10.1111/jdv.70179 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 10.11.2025. Verfasst von Yaohua Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Worldwide Medical Center, Huashan Hospital, Fudan University, Shanghai, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Open Fund Project of Key Lab of Dermatology, Ministry of Education, Anhui Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Janus kinase inhibitorbaricitinibefficacyretrospective studyruxolitinibvitiligo

Autor:innen und Institutionen

  • Worldwide Medical Center, Huashan Hospital, Fudan University, Shanghai, China.
  • Department of Dermatology of First Affiliated Hospital, and Institute of Dermatology, Anhui Medical University, Hefei, Anhui, China.
  • Department of Dermatology, The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital; Medical Center of Soochow University), Suzhou, Jiangsu, China.
  • Department of Dermatology, China-Japan Friendship Hospital, Beijing, China.
  • Dermatology Center in Boao Super Hospital, Qionghai, Hainan, China.
  • Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.

ORCID-Profile: Yaohua Zhang, Tingting Zhu, Yong Cui, Xuejun Zhang, Leihong Xiang, Bo Zhang

Förderung

  • Open Fund Project of Key Lab of Dermatology, Ministry of Education
  • Anhui Medical University

Zitieren

APA

Zhang, Y., Zhu, T., Tang, X., Li, W., Huang, H., Sheng, Y., Li, M., Cui, Y., Zhang, X., Xiang, L., & Zhang, B. (2026). Topical ruxolitinib ± oral baricitinib in the treatment of active non‐segmental vitiligo: A retrospective analysis. Journal of the European Academy of Dermatology and Venereology, 40(8). https://doi.org/10.1111/jdv.70179

Vancouver

Zhang Y, Zhu T, Tang X, Li W, Huang H, Sheng Y, et al. Topical ruxolitinib ± oral baricitinib in the treatment of active non‐segmental vitiligo: A retrospective analysis. Journal of the European Academy of Dermatology and Venereology. 2026;40(8). doi:10.1111/jdv.70179

BibTeX
@article{Zhang2026,
  author = {Zhang, Yaohua and Zhu, Tingting and Tang, Xianfa and Li, Weiran and Huang, He and Sheng, Yujun and Li, Min and Cui, Yong and Zhang, Xuejun and Xiang, Leihong and Zhang, Bo},
  title = {Topical ruxolitinib ± oral baricitinib in the treatment of active non‐segmental vitiligo: A retrospective analysis},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2026},
  volume = {40},
  number = {8},
  doi = {10.1111/jdv.70179}
}
Kostenlos starten →